Grumpy-XL schreef op 26 januari 2023 20:44:
Nog een clinical trial update van pharming - nu ruconest:
clinicaltrials.gov/ct2/history/NCT051...Verandert van single naar multi-center. Completion date nu maart 2025. Was januari 2024.
“ Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation (PAIR-TAVI)”
Hoe vaak wordt TAVI gedaan (Annual number of candidates for transcatheter aortic valve implantation per country: current estimates and future projections)
“ Currently, approximately 180 000 patients can be considered potential TAVI candidates in the European Union and in Northern-America annually. This number might increase up to 270 000 if indications for TAVI expand to low-risk patients. These findings have major implications for health care resource planning in the 29 individual countries.”
pubmed.ncbi.nlm.nih.gov/29546396/